Booster dose effective against Omicron, finds UK study
In its latest technical briefing, the company stated that two doses of each the Oxford/AstraZeneca — administered in India as Covishield — and Pfizer/BioNtech vaccines present “a lot decrease ranges” of safety against symptomatic an infection in comparison with the presently dominant Delta variant of Covid-19. However, a 3rd top-up dose does appear to spice … Read more